Our present study, as the largest sample size study to date, with external validation from an independent population, showed that MALAT1 expression was not associated with prognosis in CRC patients and that MALAT1 may have a potential tumor suppressive role in certain subpopulations. Here, MALAT1 is linked to neoplasm.